NFKB1 and depressive symptom measurement: Our experimental validation of NF-κB pathway activation (evidenced by an increased p-IκB-α/IκB-α ratio and enhanced p-p65 expression) provides direct molecular evidence that SCI-induced neuroinflammation underlies the comorbidity of depression.